TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.

Thomas Yau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.